We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT03492918
Brief Title: Pembrolizumab in Combination With Paclitaxel in the Hormone Receptor-positive Metastatic Breast Cancer With High Tumor Mutational Burden Selected by Whole Exome Sequencing: Korean Cancer Study Group Trial (KCSG BR20-16)

First Submitted : April 1, 2018
First Submitted that Met QC Criteria : April 8, 2018
First Posted : April 10, 2018

Last Update Submitted that Met QC Criteria : March 14, 2022
Last Update Posted : March 15, 2022